{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:07:01Z","timestamp":1795036021971,"version":"4.10.2"},"reference-count":44,"publisher":"EDITORA SCIENTIFIC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. J. Psychiatry"],"DOI":"10.1590\/1516-4446-2017-0015","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T11:44:53Z","timestamp":1539776693000},"page":"9-14","source":"Crossref","is-referenced-by-count":217,"title":["Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test"],"prefix":"10.47626","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2283-5231","authenticated-orcid":false,"given":"Ila M.","family":"Linares","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP),  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio W.","family":"Zuardi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP),  Brazil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq),  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina H.","family":"Queiroz","sequence":"additional","affiliation":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq),  Brazil; Faculdade de Ci\u00eancias Farmac\u00eauticas de Ribeir\u00e3o Preto,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[{"name":"Institute for Drug Research, Faculty of Medicine, Hebrew University,  Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq),  Brazil; Faculdade de Medicina de Ribeir\u00e3o Preto,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Crippa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo (USP),  Brazil; Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq),  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27448","published-online":{"date-parts":[[2019,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S1516-44462006000200015","article-title":"History of cannabis as a medicine: a review","volume":"28","author":"Zuardi AW","year":"2006","journal-title":"Rev Bras Psiquiatr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi AW","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi MM","year":"2011","journal-title":"Curr Drug Saf"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos AC","year":"2016","journal-title":"Pharmacol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0269881112474524","article-title":"Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats","volume":"27","author":"Chagas MH","year":"2013","journal-title":"J Psychopharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati TV","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky O","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ptr.4781","article-title":"Cannabidiol in inflammatory bowel diseases: a brief overview","volume":"27","author":"Esposito G","year":"2013","journal-title":"Phytother Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11607\/ofph.1274","article-title":"The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review","volume":"29","author":"Boychuk DG","year":"2015","journal-title":"J Oral Facial Pain Headache"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas MH","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"ref11","first-page":"S56","article-title":"[Therapeutical use of the cannabinoids in psychiatry]","volume":"32","author":"Crippa JA","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es FS","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi AW","year":"1993","journal-title":"J Psychopharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira FA","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos JI","year":"2010","journal-title":"Behav Brain Res"},{"key":"ref16","first-page":"1002","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi ES","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos AC","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pbb.2015.11.002","article-title":"Reprint of \u201cCaffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)\u201d","volume":"139","author":"Nazario LR","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"ref19","first-page":"251","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behaviour","volume":"6","author":"Silveira Filho NG","year":"1981","journal-title":"Res Commun Psychol Psychiatr Behav"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"ElBatsh MM","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi AW","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya S","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi MM","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli P","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa JA","year":"2011","journal-title":"J Psychopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S1516-44462001000300008","article-title":"Confiabilidade da \u201cEntrevista cl\u00ednica estruturada para o DSM-IV \u2013 vers\u00e3o cl\u00ednica\u201d traduzida para o portugu\u00eas","volume":"23","author":"Del-Ben CM","year":"2001","journal-title":"Rev Bras Psiquiatr"},{"key":"ref27","series-title":"Structured clinical interview for DSM-IV Axis I disorders -- clinician version (SCID-CV)","author":"First MB","year":"1997"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00436092","article-title":"Simulated public speaking as a model of clinical anxiety","volume":"77","author":"McNair DM","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/026988118700100305","article-title":"Effect of chlorimipramine and maprolitine on experimental anxiety in humans","volume":"1","author":"Guimar\u00e3es FS","year":"1987","journal-title":"J Psychopharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","article-title":"Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography","volume":"37","author":"Agurell S","year":"1981","journal-title":"Experientia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt SJ","year":"2008","journal-title":"Biol Psychiatry"},{"key":"ref32","first-page":"403","article-title":"Estudo transcultural de uma escala de auto-avalia\u00e7\u00e3o para estados subjetivos","volume":"30","author":"Zuardi AW","year":"1981","journal-title":"J Bras Psiquiatr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(71)90039-6","article-title":"The action of sedatives on brain stem oculomotor systems in man","volume":"10","author":"Norris H","year":"1971","journal-title":"Neuropharmacology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi AW","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref35","series-title":"Crit\u00e9rio de classifica\u00e7\u00e3o socioecon\u00f4mica Brasil (CCSEB)","year":"2008"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos AC","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos AC","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon AP","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto PC","year":"2010","journal-title":"Behav Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2014.00010","article-title":"Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain","volume":"5","author":"Levin R","year":"2014","journal-title":"Front Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fphar.2017.00391","article-title":"Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats","volume":"8","author":"Genaro K","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT receptors are involved in the cannabidiol- induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel LB","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-014-0197-5","article-title":"Delta-9-tetrahydrocannabinol\/cannabidiol (Sativex\u00ae): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis","volume":"74","author":"Syed YY","year":"2014","journal-title":"Drugs"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1590\/S0100-879X2000000500013","article-title":"Effects of tryptophan depletion on anxiety induced by simulated public speaking","volume":"33","author":"Monteiro-dos-Santos PC","year":"2000","journal-title":"Braz J Med Biol Res"}],"container-title":["Brazilian Journal of Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v41n1\/1516-4446-rbp-1516444620170015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T16:14:44Z","timestamp":1654532084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462019000100009&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["S1516-44462019000100009"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2017-0015","relation":{},"ISSN":["1809-452X","1516-4446"],"issn-type":[{"value":"1809-452X","type":"electronic"},{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}